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Summary
There is controversy over the use of the Ross procedure with regard to the sub-coronary and root replacement technique and its long-
term durability. A systematic review of the literature may provide insight into the outcomes of these two surgical subvariants. A systematic
review of reports between 1967 and February 2013 on sub-coronary and root replacement Ross procedures was undertaken. Twenty-four
articles were included and divided into (i) sub-coronary technique and (ii) root replacement technique. The 10-year survival rate for a
mixed-patient population in the sub-coronary procedure was 87.3% with a 95% conﬁdence interval (CI) of 79.7–93.4 and 89.1% (95% CI,
85.3–92.1) in the root replacement technique category. For adults, it was 94 vs 95.3% (CI, 88.9–98.1) and in the paediatric series it was 90
vs 92.7% (CI, 86.9–96.0), respectively. Freedom from reoperation at 10 years was, in the mixed population, 83.3% (95% CI, 69.9–93.4) and
93.3% (95% CI, 89.4–95.9) for sub-coronary versus root replacement technique, respectively. In adults, it was 98 vs 91.2% (95% CI, 82.4–
295.8), and in the paediatric series 93.3 vs 92.0% (95% CI, 86.1–96.5) for sub-coronary versus root replacement technique, respectively.
The Ross procedure arguably has satisfactory results over 5 and 10 years for both adults and children. The results do not support the
advantages of the sub-coronary technique over the root replacement technique. Root replacement was of beneﬁt to patients undergoing
reoperations on neoaorta and for long-term survival in mixed series.
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INTRODUCTION
In the search for an ideal substitute for the aortic valve, a tech-
nique of the pulmonary valve implantation in the aortic position
was invented. Currently, two modalities of this surgical procedure
are accepted: the sub-coronary and root replacement tech-
niques. In the sub-coronary modality, free dissected leaﬂets of
the pulmonary root were implanted in a sub-coronary position
in the aortic root [1] (Fig. 1). This, because it is a technically
demanding procedure, did not gain wide acceptance [2] among
paediatric and adult cardiac surgeons. However, with the in-
vention of root replacement (Fig. 1) in the late 1980s, the Ross
procedure underwent a renaissance. The technique whereby the
aortic root is replaced with a pulmonary root autograft is tech-
nically easier to perform than sub-coronary implantation [1, 2].
Wide acceptance of the root replacement technique was a
consequence.
Implantation of the pulmonary root in the aortic root position
may be considered a haemodynamically perfect substitute for
a native aortic valve; however, the Ross procedure remains a
double valve replacement and therefore has all the potential
disadvantages of such a procedure. The main concerns four
decades after the ﬁrst implantation are structural and non-
structural failures of the pulmonary autograft and of the homograft
in the right ventricular outﬂow tract (RVOT), with a requirement
for reinterventions. It was postulated that 15 years after surgery,
about a quarter of the implanted pulmonary autografts failed.
Age, gender, preoperative aortic root anatomy and the modality
of the surgical intervention, sub-coronary versus root replacement
technique, were thought to be predictive factors for autograft
failure [3, 4]. The sub-coronary technique was considered advanta-
geous over root replacement (Fig. 1).
However, information in recent literature on the long-term out-
comes of the two surgical modalities is not conclusive, and there
is no randomized study comparing these two Ross modalities. The
aim of this systematic review of all available evidence of the Ross
procedure with a follow-up of 10 years was to improve our knowl-
edge on the outcomes of the procedure and contribute to the
understanding of neoaortic root failure that often occurs following
the procedure. The goal is to compare the long-term results of the
sub-coronary versus the root implantation techniques in adult,
mixed and paediatric populations in order to deﬁne the incidence
of major cardiovascular events and the failure rate of the neoaortic
root and RVOT conduit.†The second and third author are equally contributing co-authors.
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MATERIALS ANDMETHODS
Search strategy
On February 2013, a PubMed and EMBASE search of (aortic valve
replacement AND autograft) OR (aortic valve replacement AND
Ross procedure) OR (Ross procedure AND pulmonary valve
replacement) was conducted, limited to publications from 1967
until 2011 in humans. In addition, the entire Cochrane library was
searched for (autograft aortic valve replacement) OR (Ross proced-
ure) OR (Ross procedure AND pulmonary valve replacement) in the
title, abstract or keywords of publications. Manuscripts written in
English, German and French languages were considered.
Two reviewers (Mirza Muradbegovic and Daniel Haselbach)
screened the titles and abstracts of identiﬁed studies. A third inde-
pendent reviewer (Denis A. Berdajs) assessed whether inclusion
and exclusion were performed correctly. In case of disagreement,
an agreement was negotiated between all three reviewers.
References of selected articles were crosschecked for other rele-
vant studies. Authors were contacted when a publication could
not be obtained or when additional information was required.
Inclusion/exclusion criteria
The review included observational studies reporting on mortality
and/or morbidity after autograft aortic valve or root replacement,
with a completeness of follow-up 90% (high quality), and a study
size of n > 30, reﬂecting the centre’s experience. In the case of
multiple publications on the same patient population, the most
recent report was selected.
Data extraction
Microsoft Excel and Review Manager version 4.2 for Windows
(The Cochrane Collaboration, 2003) were used for data extraction
and data storage. To control for potential heterogeneity caused by
patient age, publications were allocated to the following categor-
ies: (i) consecutive series in both children and adults, (ii) adult
patient series (adults and/or children aged ≥15 years at the time of
the procedure) and (iii) paediatric patient series. The study design
is documented for each paper meeting the inclusion criteria.
Outcome events were registered according to the 2008 American
Association for Thoracic Surgery/Society of Thoracic Surgeons/
European Association for Cardiothoracic Surgery guidelines [5].
Primary and secondary end points
Primary end points were deﬁned as: in-hospital mortality (within
30 days post-surgery), mortality during follow-up, reoperation rate
at long term and short term for neoaorta and RVOT conduit.
Secondary end points were deﬁned as the incidence of a major
cardiovascular event (thromboembolic event and myocardial in-
farction), rate of neoaorta endocarditis and incidence of structural
and non-structural deterioration of the neoaorta and RVOT
conduit. Structural valve deterioration and nonstructural valve de-
terioration were diagnosed either at reoperation or at autopsy
with regard to the surgical implantation technique.
Preoperative factors such as, age, gender, indication for surgery
and previous interventions were investigated to identify predictive
factors for neoaorta and RVOT reintervention in sub-coronary
versus root replacement technique.
Data on survival, event-free survival and reoperation were
required to be available for a follow-up period of more than 5
years in order for a study to be included in this systematic review.
Statistical analysis
Descriptive statistics for the population characteristics of the
included studies, i.e. year of study, number of patients, mean patient
age and range, gender distribution, New York Heart Association
(NYHA) classiﬁcation and preoperative ejection fraction are dis-
played. Results of the outcomes are considered in groups of combi-
nations between patient series (mixed, adult, child) and procedure
(Ross, sub-coronary; Ross, root replacement). The primary and sec-
ondary end points are proportions of patients with speciﬁc condi-
tions; therefore, the single individual proportions are displayed per
study, together with an overall pooled estimate of the proportion.
A random effects model was assumed to account for unexplained
heterogeneity between studies, and the DerSimonian–Laird estima-
tor was used for between-study variance ([6], p.285ff.). All statistical
analyses were performed with R for Windows [7].
RESULTS
Searching the databases for the relevant mesh terms led to 870
publications. Through the reading and evaluation process, 212
manuscripts were found to be suitable for inclusion. Thirty-ﬁve
manuscripts were excluded for the following reasons: number of
cases was <20 (n = 6), overlap with other studies (n = 4), no speciﬁ-
cation of the Ross procedure technique (n = 10), only abstract pub-
lished (n = 15). Consequently, the full-text was retrieved for 177
studies and data were extracted. Of these, 73 studies had reported
on survival with a follow-up of more than 5 years. Event-free sur-
vival for a follow-up of more than 5 years was reported in 31
Figure 1: Schematic drawing of the root replacement technique (A) and sub-
coronary implantation technique (B). Note in both schematic drawings that the
aortic root is viewed from the posterior side. The left and the right atrium were
removed. (A) The root replacement technique is seen with horizontal suture
line at the neoaortic root base and sinutubular junction. In this case, the left
and right coronary artery ositum has to be reimplanted into the wall of the
neoaortic root. (B) Sub-coronary implantation technique is seen. Here, the
suture line is positioned under the ostium of the left and right coronary artery.
Note that the suture line has a semilunar shape and is placed at nadirs of the
native aortic valve leaﬂets. In this technique, there is no need for reimplantation
of the coronary ostia. 1. Right ventricle, 2. left ventricle, 3. pulmonary artery,
4. mitral valve, 5. tricuspid valve, 6. right coronary artery and 7. left coronary
artery.
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studies, including reoperations with a follow-up of more than 10
years in 26 studies (Table 1). Two studies had no speciﬁcation on
patient age. Thus, 24 studies were included in the detailed analysis
and evaluation. Of these, 5 series were related to the isolated sub-
coronary technique (n = 1355 patients), 16 series to the root re-
placement technique (n = 2146 of patients) and 3 series to both
sub-coronary and root replacement techniques (n = 536 patients).
Adult and mixed series were described in 20 reports on 3718
patients and paediatric in 4 reports on 319 patients.
Further, 13 studies (n = 1719 patients) reported on survival with
a follow-up of more than 10 years, 4 studies (n = 861 patients) on
the sub-coronary implantation technique and 9 studies (n = 858
patients) on the root replacement technique. Event-free survival
for a follow-up of more than 10 years was reported in all 13
studies (Table 1). Table 1 provides an overview of the publications
obtained by the review.
Descriptive statistics, including mean and range of study
characteristics, are displayed in Table 2. Studies presenting iso-
lated sub-coronary implantation of the pulmonary valve were
published between 1979 and 2006, whereas studies reporting
results with root replacement technique are from 1999 and 2010.
The mean age of patients in studies of the sub-coronary technique
was 38.2 (range, 30.0–45.7) years and was 28.9 (range, 8.0–50.0)
years for root replacement. Male patients comprised 79.6% (range
78.0–81.9) of sub-coronary studies and 71.1% (55.6–86.8) of root
replacement studies. The indication for intervention was stenosis
of aortic valve in 27.3% of the overall population. In the sub-
coronary procedure, aortic valve stenosis was the indication in
21.5% (range, 13.3–31.5%) of patients, and in 28.4% (range, 4.9–
58.1%) for the root replacement technique. Regurgitation was the
indication for surgery in 36.9% of the patients overall, 39.5% in the
sub-coronary technique patients and 36.4% for root replacement.
Pooled results of the primary and secondary outcomes for groups
of studies are given in Table 3, including 5- and 10-year results
separately in adult and paediatric cohorts.
Root versus sub-coronary implantation technique
In the mixed cohort, freedom from in-hospital mortality was
95.8% (CI, 88.6–99.6) for the sub-coronary technique and 95.6%
(CI, 93.5–97.0) for the root replacement technique. Survival at 5
years was 96.2% (CI, 92.4–98.1) in the sub-coronary and 96.7%
(83.5–99.4) in the root replacement series. At 10 years, this was
87.3% (CI, 79.7–93.4) in the sub-coronary technique patients and
89.1% (CI, 85.3–92.1) in the root replacement patients (Table 3).
Freedom from reoperation on neoaorta in the mixed series at 5
years was 95.5% (CI, 90.1–98.0) in the root replacement technique
and 90.6% in the sub-coronary technique, at 10 years this was
93.3% (CI, 89.4–95.9) and 83.3% (CI, 69.9–93.4), respectively.
For each of the sub-coronary and root replacement techniques,
only one manuscript with a follow-up of 5 years was found that
covered RVOT reintervention rates in a mixed population [8, 9].
Sievers et al. [9] showed a freedom of reoperation on RVOT of 97%
in their series of 347 cases of sub-coronary implantation, which
was lower than the rate published by Kumar et al. [8], where this
value was 100% in the root replacement group. At 10 years, in the
root replacement group the freedom from RVOT reoperation was
84.0% (CI, 76.5–89.3) and 77.8% (53.1–95.1) in the sub-coronary
technique patients (Table 3). The reasons for RVOT as well as for
neo-aorta reoperations are listed in detail in Table 4. In the mixed
cohort, freedom from a major cardiovascular event at 5 years was
91.6% (CI, 88.5–93.9) in the sub-coronary technique patients and
86% (CI, 74.1–93.3) in the root replacement technique patients. At
Table 1: Publications overview
Author Year of publication Time span Number of patients Procedure Follow-up (months) Mean age of patients (years) Age range (years)
Somerville 1979 1967–1972 85 Ross 1 33 12–54
Gula 1979 1967–1977 188 Ross 1 30 9–64
Matsuki 1988 1967–1986 241 Ross 1 9–60
Chambers 1997 1967–1984 131 Ross 1, 2 240 32 11–52
Elkins 1999 1987–1999 244 Ross 2 36 22 0–62
Knott-Craig 2000 1986–1999 145 Ross 2 30 35 17–82
Elkins 2001 1986–2001 178 Ross 1,2 62.6 9.6 0–17
Oswalt 2001 1990–2001 191 Ross 2 0–69
Sievers 2003 1994–2002 245 Ross 1 29.4 45.7 15–70
Takkenberg 2005 1988–2003 47 Ross 2 73 8 0.25–15
Settepani 2005 1991–2003 103 Ross 2 72 35.2 17–65
Sampath 2005 1993–2003 153 Ross 2 77 28 0.7–65
Hazekamp 2005 1994–2003 53 Ross 2 66 9.7 0–17.7
Ruzmetov 2006 1991–2001 81 Ross 2 92.4 31 16–52
Kumar 2006 1993–2003 81 Ross 2 92.3 29.5 11–56
Sievers 2006 1994–2005 347 Ross 1 45.6 44 14–71
Da Costa 2006 1995–2005 227 Ross 1,2 45.5 29.1 5–56
Klieverik 2008 1987–2007 63 Ross 2 123.6 29 16–52
Favarolo 2008 1995–2006 165 Ross 2 57 39 16–65
Özaslan 2008 1996–2007 50 Ross 2 74.4 50 13–63
El Behery 2009 1991–2003 41 Ross 2 72 10.17 0.45–18.3
Da Costa 2009 1995–2006 272 Ross 2 67 30 5–56
Hamamsy 2010 1994–2001 108 Ross 2 122.4 38 19–66
Roura 2010 1995–2008 198 Ross 2 69.8 39 16–65
Overview of publications included in analysis.
Ross 1: sub-coronary implantation technique; Ross 2: root replacement technique.
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10 years, this was 84.0% (CI, 76.5–89.3) and 77.8% (CI, 53.1–95.1),
respectively (Table 3).
In the adult series (n = 8 manuscripts), there were no reports on
the sub-coronary technique with 5-year survival, and only one
manuscript describing results with a 10-year follow-up on sub-
coronary technique was included [10]. Freedom from in-hospital
mortality was 99.2% in the sub-coronary technique group and
97.5% (CI, 95.6–98.5) in the root replacement technique group.
Survival rate at 10 years in the sub-coronary group was 94% and in
the root replacement group was 95.3% (CI, 88.9–98.1). Freedom
from neoaorta reintervention was 98% [10] in the sub-coronary
group and 91.2% (CI, 82.4–95.8) in the root replacement tech-
nique patients. For RVOT, the freedom from reoperation was
97.0% [10] and 95.9% (CI, 90.6–98.3) (Table 3). Freedom from a
major cardiovascular event at 10 years was 97% [10] in the sub-
coronary group and 87% (CI, 76.5–93.4) in the root replacement
group (Table 3).
In the paediatric (age <15 years) series, four publications were
included. The sub-coronary technique was evaluated in one
report [11], with the follow-up results of 10 years. Freedom from
in-hospital mortality was 95.5% in the sub-coronary technique
group and 96.3% (CI 91.1–98.5) in the root replacement technique
patients. Survival at 10 years was 90% [11] in the sub-coronary and
92.7% (CI, 81.3–97.4) in the root replacement groups [11].
Freedom from neoaorta reintervention was 93.3% [11] in the sub-
coronary and 92.9% (CI, 86.1–96.5) in the root replacement
technique group. For RVOT, this was 89.9% (9) and 92.6% (90.2–
97.9), respectively (Table 3). Freedom from a major cardiovascular
event at 10 years was 93.3% [11] in the sub-coronary and 92.9%
(CI, 86.1–96.5) in the root replacement group.
Reasons for RVOT as well as for neoaorta reoperations are listed
in detail in Table 4.
DISCUSSION
The Ross procedure is an alternative to aortic valve replacement
in adults and in paediatric populations. The advantages of the
Ross procedure, compared with the commercially available aortic
valve prosthesis, are in its superior haemodynamic performance,
minimal incidence of thromboembolic and infective events and
potential for growth in paediatric cases. Since the ﬁrst implant-
ation by Donald Ross [1] in the late 1970s, considerable experience
has been accumulated. Currently, two modalities of the surgical
technique are accepted: the sub-coronary and root replacement
techniques (Fig. 1). The root replacement technique gained ac-
ceptance by both paediatric and adult cardiac surgeons due to its
less demanding implantation technique and predictability in the
short term. Because of the excellent results of root replacement in
the short term, in the late 1990s, the ideal substitute for the aortic
valve was considered to have been found [2, 3, 9, 11, 12]. However,
results over the ﬁrst 5 years showed that in addition to RVOT
Table 2: Summary of population characteristic’s
Study characteristics Mean (SD) Range NA’s
Year of publication 2002 1979–2010
Sub-coronary 1990 1979–2006
Root replacement 2006 1999–2010
Mean age of patients at intervention 30.9 (11.7) 8–50 4
Sub-coronary 38.2 (7.8) 30–45.7 2
Root replacement 28.9 (12.0) 8–50 2
Number of patients 152.2 (85.9) 41–347
Sub-coronary 225.8 (86.1) 85–347
Root replacement 126.2 (71.3) 41–272
% Male gender 72.8% 55.6–86.8 3
Sub-coronary 79.6% 78.0–81.9 2
Root replacement 71.1% 55.6–86.8 1
NYHA classification I–II (%) 65.7% 25.5–83.5 15
NYHA classification III–IV (%) 33.2% 14.9–74.5 15
Indication for surgery (stenosis) (%) 27.3% 4.9–58.1 4
Subcoronary 21.46% 13.3–31.5 3
Root replacement 28.4% 4.9–58.1 1
Indication for surgery (regurgitation) (%) 36.9% 8.6–72.8 3
Sub-coronary 39.5% 32.0–52.7 3
Root replacement 36.4% 8.6–72.8 0
Indication for surgery (mixed) (%) 41.3% 22.2–75.6 5
Sub-coronary 43.4% 30.6–54.2 3
Root replacement 40.9% 22.2–75.6 2
Previous interventions (ballon) (%) 13.8% 0.3–42.6 14
Previous interventions (open surgery) (%) 17.7% 1.2–46.8 10
Associated procedures, total number (%) 25.0% 3.7–67.2 3
Sub-coronary 25.9% 12.9–47.8 1
Root replacement 24.7% 3.7–67.2 2
Duration of cardiopulmonary bypass (min) 179 116–214 9
Mean cross-clamp time (min) 132.2 94–174 7
Mean duration hospital stay after surgery (days) 9.9 8–12 19
Descriptive statistics for the 26 studies with more than 5-year follow-up time. Herein, the preopertive and intraoperative variables may be seen.
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Table 3: Mixed, adult and paediatric patient cohorts with primary end points, by procedure and series
Study Survival Freedom of major cardiovascular
event
Freedom of reoperation on
neoaorta
Freedom of reoperation on RVOT
30 days 5 years Maximal 5 years 10 years 5 years 10 years 5 years 10 years
(A) Mixed patients cohort with primary end points, by procedure and series
Sub-coronary implantation
Somerville (1979) – 94 87 94.1 90.6 91.8 80 – 94.1
Gula (1979 91 – 82 – 86.7 82.4 78.2 – 80.9
Matsuki (1988) 93.4 – 83 – 40.5 85.1 74.7 – –
Sievers (2006) 99.4 97 94 (8 years) 91.0 84 97.0 95 97.0 95
Overalla 95% CIb 95.8 (88.6–99.6) 96.2 (92.4–98.1) 87.3 (79.7–93.4) 91.6 (88.5–93.9) 77.8 (53.1–95.1) 90.6 (81.5–) 83.3 (69.9–93.4) – 90.9 (80.5–97.8)
Root replacement
Elkins (1999) 98.0 86 91.0 84 98.0 95.9 91.8
Oswalt (2001) 94.8 90.2 88.5 85.9 91.6 90.6
Sampath (2005) 93.5 88.3 86.9 75.0 68.3 91.8 87 –
Kumar (2006) 92.6 84.4 (9 years) 84 94.0 93 100.0 100
Özaslan (2008) 100 100.0 100 84 90 98
Da Costa (2009) 97.1 93 (12 years) 90.5 97 95
Overalla 95% CI 95.6 (93.5–97.0) 96.7 (83.5–99.4) 89.1 (85.3–92.1) 86.4 (74.1–93.3) 84.0 (76.5–89.3) 95.5 (90.1–98.1) 93.3 (89.4–95.9) – 93.8 (90.2–96.1)
Sub-coronary and root replacement
Chambers (1997) 97.7 – 85 – 26.7 – 89.3 – 89.3
Da Costa (2006) 96.5 94.2 93.5 – 89.4 – 96.4 – 96.2
Overalla 95% CI 97.2 (94.8–98.5) – 90.4 (78.8–96.0) – 63.7 (7.5–97.5) – 93.7 (82.3–97.9) – 93.7 (82.3–97.9)
(B) Adult patients cohort with primary end points, by procedure and series
Sub-coronary implantation
Sievers (2003) 99.2 – 94 – 97 – 98 – 97
Root replacement
Knott-Craig (2000) 94 97 77 91 73 87.6 – 87.6
Settepani (2005) 100 97.3 96.3 75.4 98.7 87.4 – 98.7
Ruzmetov (2006) 97.6 97.4 98.7 87 – –
Klieverik (2008) 96.8 96.8 (13 years) 59.2 100.0 63.4 – –
Favarolo (2008) 97.5 94.8 91 96.3 – 100
El-Hamamsy (2010) 99 97 97 96.2 100.0 99 – 95
Roura (2010) 97.5 94.8 91 91 95 – 95
Overalla 95% CI 97.4 (95.6–98.5) 97.2 (94.3–98.7) 95.3 (88.9–98.1) 92.6 (88.2–95.4) 87.1 (76.5–93.4) 99.2 (97–99.8) 91.2 (82.4–95.8) – 95.9 (90.6–98.3)
(C) Paediatric patients cohort with primary end points, by procedure and series
Root replacement
Takkenberg (2005) 100 93.0 93 97.0 92 93.6 91.5 93.6 89.4
Hazekamp (2005) 94.4 92.4 89 93.0 89 93.0 89 97.0 97
El Behery (2009) 95 95.0 95 85.3 75.7 100 100 97.0 89
Overalla 95% CI 96.3 (91.1–98.5) 93.5 (88.0–96.6) 92.7 (86.9–96.0) 92.8 (81.3–97.4) 88.0 (75.6–94.5) 95.6 (90.2–98.1) 92.9 (86.1–96.5) 95.6 (90.2–97.9) 92.6 (85.4–96.4)
Sub-coronary implantation
Elkins (2001) 95.5 – 90 (12 years) – 73 – 93.3 – 89.9
All numbers in percent. Note that all numbers are expressed in %.
aRandom effects model, DerSimonian-Laird estimator for between study variance.
bConfidence interval.
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conduit failure, there was also considerable rate of neoaortic root
deterioration with need for reintervention [9,11,13]. More com-
prehensive analysis of the long-term results, including one
meta-analysis, indicated that surgical technique, female gender,
age, preoperative aortic valve pathology (such as bicuspid valve or
annular dilatation) were predictive factors for neoaorta dilatation
[3,10,11, 14].
A recent analysis focused on the impact of two Ross procedure
modalities on survival and reoperation rates. The surgical tech-
nique of pulmonary valve implantation into the left ventricular
outﬂow tract was considered one of the independent variables
that may inﬂuence the long-term durability of the pulmonary
valve in the aortic position. The sub-coronary technique was
advocated as a preventive factor for late root dilatation and con-
sequent neoaorta structural deterioration [10,11]. However,
because of its complexity, this procedure is not broadly accepted.
In the present review, in adult and pediatric populations, one-
one series on sub-coronary implantation technique was found. In
contrast in mixed populations six papers on both techniques
were included.
The root replacement technique was described in 18 manu-
scripts included in this review, and in most cases a freestanding
root implantation technique was used (in two manuscripts there
was no age speciﬁcation of the cohort). This technique was par-
ticularly widely used in the early 1990s. Later, with the accumula-
tion of evidence of long-term survival, neoaortic root dilatation
became more obvious. The rate of neoaortic root dilatation was
estimated at 0.5 mm/year [15] in an adult and 2 mm/year in a
mixed population [16]. The preoperative aortic valve regurgitation
was identiﬁed as an independent predictive factor [17] for
neoaorta dilatation. The dilatation of the aortic root supporting
structures at the distal anastomosis line may be a reason for this
late dilatation. The medical history of hypertension was not found
as a predictive factor, for ne-aorta dilatation [17].
Table 4: Mixed, adult and paediatric patient cohorts with secondary end points, by procedure and series
Study Neoaorta pathology RVOT
Infection rate Structural deterioration Non-structural deterioration Stenosis Insufficiency Non-specified
(A) Mixed, patients cohort with secondary end points, by procedure and series
Sub-coronary implantation
Somerville (1979) 8.2 5.9 7.1 1.2 4.7 –
Gula (1979) 2.1 2.1 – – – –
Matsuki (1988 5.8 – 6.6 – – –
Sievers (2006) 1.2 1.2 – 0.9 0.9 –
Overalla 95% CIb 3.7 (1.7–7.8) 2.7 (0.7–5.9) 7.0 (4.4–10.0) 0.9 (0.4–2.5) 2.3 (0.6–9.0) –
Root replacement
Elkins (1999) 0.4 1.2 1.2 – – –
Oswalt (2001) 2.1 6.3 1.6 1.0 – 3.1
Sampath (2005) 3.3 4.6 0.7 – – –
Kumar (2006) 1.2 6.2 0.0 0.0 0.0 0.0
Özaslan (2008) 4.0 4.0 6.0 2.0 0.0 –
Da Costa (2009) 1.5 0.7 0.4 1.5 0.0 –
Overalla 95% CI 2.4 (1.5–3.9) 3.7 (1.9–6.9) 1.7 (0.9–3.3) 1.2 (0.6–2.6) 0.5 (0.1–2.3) 2.3 (0.7–7.7)
Root replacement and sub-coronary implantation
Chambers (1997) 6.1 2.3 20.6 15.3 3.1 –
Da Costa (2006) 0.4 1.8 0.4 1.8 – –
Overalla 95% CI 2.0 (0.2–21.4) 2.6 (1.3–4.8) 3.7 (0.1–67.2) 5.6 (0.6–36.2) – –
(B) Adult patients cohort with secondary end points, by procedure and series
Sub-coronary implantation
Sievers (2003) 0.4 0.4 0.4 0.8 0.8 –
Root replacement
Knott-Craig (2000) 0.7 2.1 – – – –
Settepani (2005) 1.0 4.9 0.0 1.0 0.0 1.0
Ruzmetov (2006) 1.2 13.6 0.0 – – –
Favarolo (2008) 0.0 25.4 0.0 0.0 0.0 –
Klieverik (2008) 0.0 0.6 0.6 – – 7.9
Roura (2010) 0.5 0.9 0.0 0.0 0.0 –
El-Hamamsy (2010) 0.0 1.0 0.5 5.6 0.9 –
Overalla 95% CI 1.1 (0.5–2.1) 4.1 (1.4–11.4) 0.5 (0.2–1.5) 1.1 (0.2–6.0) 0.5 (0.1–1.7) 4.4 (1.1–16.0)
(C) Paediatric patients cohort with secondary end points, by procedure and series
Sub-coronary implantation
Elkins (2001) 0.6 4.5 2.2 4.5 3.9 –
Root replacement
Takkenberg (2005) 0.0 2.1 2.1 2.1 – 2.1
Hazekamp (2005) 0.0 9.4 0.0 5.7 0.0 5.7
El Behery (2009) – 0.0 0.0 9.8 0.0 –
Overalla 95% CI – 4.4 (1.2–15.0) 1.5 (0.4–5.8) 5.3 (1.8–10.2) – 3.8 (0.7–8.8)
All numbers in percent. Note that all numbers are expressed in %.
aRandom effects model, DerSimonian-Laird estimator for between study variance.
bConfidence interval.
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To prevent the neoaorta dilatation, different modalities of root
replacement technique were applied, for example, reinforcement
with pericardial or Dacron strips at the level of the proximal suture
line became popular [8, 12, 18]. However, in most cases, dilatation
did not occur at the level of the root base but rather at the level of
the three sinuses and the sinutubular junction [9,14, 18].
No explanation was found for this phenomenon; on the one
hand, it is obvious that in case of the accompanied ascending
aorta and/or sinutubular junction dilatation, replacement of the
ascending aorta with a Dacron tube may have a stabilization effect
on the distal suture line [8, 12].
Further, considering the natural asymmetry of the aortic and
pulmonary roots, the pulmonary root should be implanted in the
following manner: the left pulmonary sinus in the position of the
right coronary sinus; the anterior pulmonary sinus should be
located in the position of the non-coronary sinus; right pulmonary
sinus in the position of left coronary sinus [19–22]. It has yet to be
proved whether this implantation technique can avoid root dilata-
tion in clinical scenarios.
The dilatation of the neoaorta sinuses following the root re-
placement was the issue of discussion for years. To prevent this
phenomenon, numerous surgical techniques of neoaorta re-
inforcement have been proposed. The root inclusion technique is
one of the most accepted techniques. Here, the pulmonary root is
included as whole cylinder inside of the native aortic root. This
technique indeed may prevent the late dilatation; however, for
objective assessment, there is a net deﬁcit of manuscripts with
long-term results on this technique. For example, in our review
only two manuscripts describing this surgical technique were
included [23, 24].
However, based on our results, we can state that in the mixed
population pool the root replacement implantation technique is
of advantage compared with the sub-coronary implantation tech-
nique at 5 and 10 years. This is true of the neoaorta reoperation
rate, freedom from major cardiovascular events and of the RVOT
reoperation rate. The higher reoperation rate in the sub-coronary
implantation technique is explained by the four times higher rate
of non-structural deterioration of the root (Table 4). Additionally,
incidence of neo-aorta endocarditis was higher for the sub-
coronary technique (Table 4). It would be interesting to determine
whether the same phenomenon may be evoked in adult and
paediatric series. Unfortunately, it was not possible to cover this in
the present review due to a lack of long-term results for these
populations. Namely in adult as well as in paediatric population
only one report dealing with 10-year results on sub-coronary
technique was found [10, 11]. This is a limitation of the recent
report, and only randomized studies in both age groups would
conﬁrm or disapprove our observation in a mixed population.
The advantage of the root replacement technique regarding
the neoaorta reoperation in the mixed population is not surpris-
ing; in sub-coronary implantation only the pathological aortic
valve is cured by replacement of the pulmonary valve. Diseased
aortic root including intervalvular triangles, wall of the sinuses,
sinutubular junction and aortic root base rest in situ, and thus
does negatively inﬂuence the function of the neoaortic root. A
combination of net pulmonary leaﬂets implanted into the dis-
eased aortic root components may be the key haemodynamic
and morphological element that ﬁnally leads to valve dysfunction
and structural deterioration. However, this hypothesis should be
proved with further clinical and experimental trials.
To reconstruct the RVOT in most cases, pulmonary homograft
was implanted, only in a few cases stentles biological valve, and
bovine jugular conduit graft were used. It appears from this study
that the rate of reoperation on RVOT is in some instances higher
in children than in adult or mixed populations. In the mixed
series, the degeneration of the RVOT conduit including stenosis
and the insufﬁciency of the conduit valve were predominant
reasons for reoperation. A higher insufﬁciency rate was registered
in the sub-coronary technique group (Table 4) compared with the
root replacement technique group. Incidence was similar in
mixed and adult populations; however, in the paediatric series the
reoperation rates were about 4.5 times higher with predominance
of the stenosis on the RVOT conduit. This, in part, may be
explained by the degenerative process in RVOT and by the out-
growth tendency in children. However, at this point of discussion
it has to be noted that the pulmonary valve implantation tech-
nique into the aortic position does not inﬂuence the durability of
the RVOT conduit. This in principle depends on conduit diameter
implanted, age, body surface and a type of the conduit. The exact
mechanism of the RVOT conduit degeneration in the paediatric as
well as in adult series has yet to be explored, and general consen-
sus is that development of more durable conduits for RVOT recon-
struction is needed [25, 26].
To conclude, we can state that our results support the excel-
lence of the Ross procedure over 10 years, with overall survival
>90%. It seems that the root replacement technique has a slight
advantage over the sub-coronary implantation technique in the
short term. This advantage is more obvious over 10 years in the
mixed series for survival, the neoaorta reoperation rate, RVOT reo-
peration rate and for the freedom from the major cardiovascular
events. The advantage of the root replacement technique may not
be stated for sure in paediatric as well as in adult series, because
of lack of series with long-term results. However, the tendency of
better outcomes of root replacement is marked at 10 years.
In our investigated population, the mean age was 30.9 ± 11.7
(range, 8–50) years, what may be considered a middle young aged
population with considered repartition of adults. Comparing the
reoperation rate on neoaorta following the Ross procedure with
reoperation for mechanical and biological aortic valve replace-
ment in young/middle-aged adults, we can say that the Ross pro-
cedure is of a deﬁnitive advantage. In a middle-aged population,
the reoperation more than 10 years after mechanical prosthesis
may reach up to 10%. In case of bioprosthesis, this may be up to
30% [27, 28] at 10 years, and 50% at 15 years [29]. According to our
analysis freedom from overall reintervention regarding the neo-
aorta and RVOT conduit replacement is superior to 93%. Freedom
of root replacement is superior to 93% in all three groups and
freedom from reintervention on RVOT in adult and mixed series is
higher than 95 and 93%, respectively. In paediatric, series this is
with 90% slightly lower.
These superior results in the recent report indicate a Ross pro-
cedure as the ﬁrst line choice for aortic valve replacement in chil-
dren, young adults and the middle-aged patients. This becomes
important in young females of childbearing age and in young
adults, because of lack of life-long anticoagulation and accom-
panying complications. Namely, yearly risk for major thrombo-
embolic event and bleeding is about 2.8 to 3% per year in
mechanical and 1.5 to 2% in biological valve [30]. To note is that
biological valve, according to recent recommendations, are
implanted in patients with age more than 60 years [31]. In this
patient population, other reasons for thromboembolic events
have to be considered, for example, atrial ﬁbrillation. Risk is cumu-
lative and linear; in other words, patients who undergo mechanic-
al aortic valve replacement at the age of 45 will suffer a stroke or
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another major thromboembolism or haemorrhagic event by the
age of 75 [28]. However, to clearly address the superior results of
the Ross procedure, as double valve intervention in young adults
over those of commercial available bioprosthesis, further clinical
randomized trails has to be done.
Conﬂict of interest: None declared.
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